Previous studies have indicated that in adult smokers, a history of childhood pneumonia is associated with reduced lung function and chronic obstructive pulmonary disease. There have been few previous investigations using genome-wide association studies to investigate genetic predisposition to pneumonia. This study aims to identify the genetic variants associated with the development of pneumonia during childhood and over the course of the lifetime. Study subjects included current and former smokers with and without chronic obstructive pulmonary disease participating in the COPDGene Study. Pneumonia was defined by subject self-report, with childhood pneumonia categorized as having the first episode at ,16 years. Genome-wide association studies for childhood pneumonia (843 cases, 9,091 control subjects) and lifetime pneumonia (3,766 cases, 5,659 control subjects) were performed separately in non-Hispanic whites and African Americans. Non-Hispanic white and African American populations were combined in the meta-analysis. Top genetic variants from childhood pneumonia were assessed in network analysis. No single-nucleotide polymorphisms reached genome-wide significance, although we identified potential regions of interest. In the childhood pneumonia analysis, this included variants in NGR1 (P = 6.3 3 10 28 ), PAK6 (P = 3.3 3 10 27 ), and near MATN1 (P = 2.8 3 10 27 ). In the lifetime pneumonia analysis, this included variants in LOC339862 (P = 8.7 3 10 27 ), RAPGEF2 (P = 8.4 3 10 27 ), PHACTR1 (P = 6.1 3 10 27 ), near PRR27 (P = 4.3 3 10 27 ), and near MCPH1 (P = 2.7 3 10 27 ). Network analysis of the genes associated with childhood pneumonia included top networks related to development, blood vessel morphogenesis, muscle contraction, WNT signaling, DNA damage, apoptosis, inflammation, and immune response (P < 0.05). We have identified genes potentially associated with the risk of pneumonia. Further research will be required to confirm these associations and to determine biological mechanisms.
Clinical Relevance
To the best of our knowledge, this study is the first to investigate the genetic factors that may be associated with pneumonia during childhood and across the lifetime. It may help identify children at risk of lung disease such as chronic obstructive pulmonary disease later in life. This could ultimately direct us toward a subtype of chronic obstructive pulmonary disease with early childhood origins and could help better prognosticate disease risk and treatment response.
Pneumonia is a common pediatric diagnosis, especially in young children, that poses a significant risk of respiratory disease later in life (1, 2) . Pneumonia is less common in adults, although smokers are a subpopulation known to experience increased rates of pneumonia (3) (4) (5) . Our previous investigations have demonstrated that pneumonia in childhood is a risk factor for chronic obstructive pulmonary disease (COPD), reduced lung function, and airway disease on chest computed tomography scans in adult smokers (6) . This variability in the prevalence of childhood pneumonia and its association with an increased risk of lung disease later in life suggest some underlying genetic susceptibility.
Few previous investigations have used genome-wide association studies (GWAS) to investigate the genetic predisposition to pneumonia (7) . The objective of this study was to identify the genetic susceptibility loci involved in the development of childhood pneumonia in adult smokers from the COPDGene study population. The primary analysis used GWAS to assess genetic associations with childhood pneumonia. We focused on childhood pneumonia because it may have an increased likelihood of being driven by genetic factors, as compared with pneumonia in adult smokers, which may be driven more by environmental factors such as smoking, an exposure known to be associated with pneumonia development (5) . A secondary analysis used GWAS to assess the history of lifetime pneumonia to identify potential common genes and pathways influencing both childhood and adult pneumonias.
We hypothesized that this GWAS would identify susceptibility loci related to both childhood and lifetime pneumonia. Furthermore, we postulated that these loci were likely to show evidence of associations with genetic variants related to lung function, lung development, immune response, COPD, and asthma. Some of the results of these studies have been reported previously in the form of an abstract (8) .
Materials and Methods

Subjects
We evaluated 10,192 current and former U.S. smokers with and without COPD from the COPDGene Study. The subjects were 45-80 years old, of non-Hispanic white (NHW) or African American (AA) race, with at least a 10 pack-year smoking history. Subjects were excluded for a history of lung disease other than COPD or asthma. COPDGene was approved by institutional review boards at each of the 21 clinical sites (9) . All participants provided written informed consent. Study protocol, enrollment criteria, and data collection forms have been described previously and are available at www. copdgene.org (9, 10) .
Data Collection
Pneumonia history was collected from responses to a modified American Thoracic Society Respiratory Epidemiology Questionnaire (10, 11) . Genotyping was performed on DNA extracted from blood samples using HumanOmniExpress (Illumina, San Diego, CA). Standard quality control measures were completed on DNA and single nucleotide polymorphism (SNP) data, as described previously (9, 12, 13) . Additional genotypes were imputed from 1,000 Genomes Phase I v3 reference panels (hg19) using minimac and MaCH (13) (14) (15) (16) . COPDGene datasets are available publicly (dbGaP accession number phs000179.v1.p1).
Case Identification
Pneumonia was defined by subject selfreport, as described previously (6) . The subjects were classified as having childhood pneumonia if their first episode was at ,16 years of age or during childhood, and lifetime pneumonia if they had ever had pneumonia. Additional subjects were excluded from lifetime pneumonia analysis for not knowing whether they had history of pneumonia.
Statistical Analysis
Four independent GWAS were performed in subjects with childhood pneumonia and lifetime pneumonia using PLINK 1.90, with initial evaluations completed separately in NHW and AA populations (17) . A logistic regression of SNPs on the basis of casecontrol status was performed, adjusted for sex and genetic ancestry (12) . Lambda (l) was calculated to assess the degree of genomic inflation after principal component adjustment (18) . Genome-wide significance for SNPs was defined as P < 5 3 10
28 (19, 20) . Results from NHW and AA populations were combined in separate metaanalyses using a fixed-effect model weighted by inverse variance (17, 21) . Sensitivity analyses were run, adjusting for pack-years of smoking and assessing subjects with multiple lifetime pneumonias.
In In single SNP analyses, annotation of variants to genes was performed using National Center for Biotechnology Information databases dbSNP/Gene, UCSC Genome Browser, and LocusZoom (23) (24) (25) (26) . For genebased analysis, SNPs were mapped to genes with VEGAS2 using the Monte Carlo approach with simulations from a multivariate normal to estimate the null distribution and to generate gene-based P values (27) (28) (29) . VEGAS2 software performs adjustment for multiple testing using a Bonferronicorrected threshold of P , 2.0 3 10
26
(z25,000 genes) (27, 28) . The resulting VEGAS2 genes from childhood pneumonia analysis with P , 0.01 were included in the network analysis using Metacore (see online supplement) (30) (31) (32) .
Results
The COPDGene Study consists of 10, 192 (Tables 1 and 2 ). Top SNPs from the pneumonia GWAS were examined for overlap with known COPD variants; there was a nominal association of CHRNA3, cholinergic receptor nicotinic ORIGINAL RESEARCH a 3 subunit, with lifetime pneumonia, which was not surprising in this cohort of smokers (13) .
Childhood pneumonia GWAS included 6,652 NHW subjects with a case prevalence of 10.3% and 3,282 AA subjects with a prevalence of 4.8% ( Figure E1 and Table E1 ). NHW analysis identified a potential region of interest near MATN1, matrilin 1, cartilage matrix protein (Tables  1 and 2 and Figure 1 ). The AA GWAS had no variants identified with P , 1.0 3 10
26 . Meta-analysis on the combined NHW and AA populations included 9,934 subjects with a childhood pneumonia case prevalence of 8.5%. Meta-analysis identified variants of interest approaching genomewide significance in NGR1, neuregulin 1 and PAK6, p21 protein (Cdc42/Rac)-activated kinase 6.
Lifetime pneumonia GWAS included 6,306 NHW subjects with a case prevalence of 45.7% and 3,119 AA subjects with a prevalence of 28.3% ( Figure E2 and Table   E1 ). NHW analysis identified a potential region of interest near MCPH1, microcephalin 1 (Tables 1 and 2 and Figure E9 ). AA analysis identified variants of interest in uncharacterized LOC339862, RAPGEF2, Rap guanine nucleotide exchange factor (GEF) 2, and PHACTR1, phosphatase and actin regulator 1. Metaanalysis of the combined NHW and AA populations included 9,425 subjects with a lifetime pneumonia prevalence of 40.0%. Meta-analysis identified variants of interest approaching genome-wide significance near PRR27, proline rich 27 (also known as C4orf40), and near MCPH1.
Gene-based analysis of childhood pneumonia SNPs using VEGAS2 identified 585 genes in the NHW population and 1,141 genes in the AA population with gene-based P < 0.01. Gene-based analysis of lifetime pneumonia SNPs found 732 genes in the NHW population and 1,159 genes in the AA population with gene-based P < 0.01.
Two genes in the childhood pneumonia analysis, RNF216P1 and TLE3, reached the Bonferroni-corrected threshold of P , 2.0 3 10 26 for significance in gene-based testing, and no genes reached this threshold in the lifetime pneumonia analysis; however, there were genes of interest with P values approaching the level of significance (Table 3) (27, 28) . The top 10 genes for childhood pneumonia included EPAS1, endothelial PAS domain protein 1, ORAI1, ORAI calcium releaseactivated calcium modulator 1, TLE3, transducing-like enhancer of split 3, and for lifetime pneumonia, included uncharacterized LOC339862.
Network analysis of childhood pneumonia genes in Metacore, performed separately for NHW and AA populations, identified association with networks including development, blood vessel morphogenesis, muscle contraction, DNA damage, cytoskeleton, cell cycle, cell adhesion, WNT signaling, inflammation, , heterogeneity index; NHW, non-Hispanic white; OR, odds ratio; Rsq, estimation of imputation quality; SNP, single-nucleotide polymorphism. *Includes the top SNP from each region where GWAS P value was <1 3 10
26
. † SNP is near these genes, not in the genes.
immune response, and apoptosis (P < 0.05) ( Table 4 ). The top network in both NHW and AA populations was related to development, specifically blood vessel morphogenesis (Table 4 and Figure E10 ).
Sensitivity Analyses
To assess whether additional adjustment for pack-years would significantly affect the lifetime pneumonia GWAS results, we repeated GWAS analyses independently in NHW and AA populations with adjustment for pack-years of smoking. No SNPs reached genome-wide significance, and the resulting top SNPs were similar (Table E2) .
To assess whether subjects who experience multiple pneumonias may have a stronger genetic association, we ran additional GWAS analyses independently in NHW and AA populations comparing subjects who reported more than one lifetime pneumonia with those with no history of pneumonia. No SNPs reached the level of genome-wide significance.
Discussion
We have presented results from, to the best of our knowledge, the first GWAS of allcause pneumonia susceptibility during childhood and over the lifetime. In a metaanalysis of smokers from two ethnic groups, we have identified potential genes and chromosomal regions of interest. No SNPs reached genome-wide significance.
In young children in the United States, the prevalence of pneumonia annually is z3-5% (2). In this GWAS population of adult smokers, the prevalence of childhood pneumonia was 8.5%. This increased prevalence in the COPDGene population was possibly related to the fact that a significant number of these subjects had risk factors for developing childhood pneumonia, including childhood asthma and living with a smoker during childhood (6) .
Variants of interest identified in the childhood pneumonia GWAS were found in NRG1, PAK6, and near MATN1, genes related to lung function, cardiovascular system growth and development, and repair processes. The top variant possibly associated with childhood pneumonia was in NRG1. NRG1 has been associated with lung function in a GWAS network analysis from the Framingham Heart Study (33) . NRG1 plays a critical role in cardiovascular system growth and development, including angiogenesis, and surfactant synthesis in the fetal lung (23, 34, 35) . NRG1 encodes neuregulin-1, a signaling protein that is part of the epidermal growth factor family, which is important in the coordination of epithelial repair processes (23, 26, 36) . Expression of specific NRG1 isoforms in human airway epithelium has been found to induce the expression of MUC5AC and 
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MUC5B protein, which are predominant mucins in asthma and COPD (37) . NRG1 has also been found to be a contributor in the pathophysiology of acute lung injury (38) . PAK6 encodes protein kinases that function in cytoskeleton rearrangement and apoptosis (23) . MATN1 is a cartilage matrix protein expressed in skeletal and cartilage tissue during embryogenesis and throughout the lifespan, which is important to both development and repair processes (39) .
Among the top NHW childhood pneumonia genes from the gene-based analysis were EPAS1, a key regulator gene in COPD, and ORAI1, which is involved in calcium channel conductance in the bronchial epithelium, smooth muscle physiology, and susceptibility to injury from cigarette smoke in both asthma and COPD (40) (41) (42) (43) . Among the top AA childhood pneumonia genes, TLE3 has been found in previous GWAS to be significantly associated with lung function as part of the THSD4-UACA-TLE3 locus in the Hutterites, a founder population from South Tyrol (44) . TLE3 codes for a transcriptional corepressor protein that is in a family of proteins that participate in the Notch signaling pathway, which plays a role in development by affecting cell fate determination (23, 26) .
Network analysis of the significant childhood pneumonia genes identified the same top network for both the NHW and the AA population, a development network related to blood vessel morphogenesis, which included EPAS1. A number of other networks related to development were present among the significant networks in the AA analysis. A network for muscle contraction was also a top finding for both the NHW and the AA population. In addition, there were shared networks in both populations for WNT signaling, which has been implicated in the pathogenesis of impaired lung function related to asthma and also to COPD (45, 46) . Interestingly, out of 30 significant networks identified in the analysis, there was only one immune response network implicated, which is less than we would have predicted given that the cases were all subjects with childhood pneumonia.
Variants identified as possibly associated with lifetime pneumonia GWAS were found in RAPGEF2, PHACTR1, and near MCPH1, genes related to vascular functions, embryonic hematopoiesis, and damage response. RAPGEF2 has been found to be critical for murine embryonic hematopoiesis and to be differentially expressed in pulmonary arterial hypertension (47, 48) . PHACTR1 plays a role in the reorganization and regulation of the actin cytoskeleton and appears to influence important vascular functions (49, 50) . MCPH1 is a gene that encodes a DNA damage response protein (23) .
Previous investigations of genetic susceptibility to pneumonia have largely been candidate gene studies. The only previous pneumonia GWAS in humans focused on sepsis caused by pneumonia and looked at the primary outcome of 28-day survival, not SNPs associated with the risk of developing pneumonia (7, 51) . In this population, the combined prevalence of childhood pneumonia and childhood asthma was 1.6%. Although it would have been interesting to run GWAS looking at genetic determinants of the shared diagnoses, the power would be too limited for this analysis (Table E1) .
Potential Limitations
We acknowledge that this investigation is limited by reliance on subject recall for classification of childhood pneumonia. Previous studies have shown that selfreported pneumonia diagnosis has a relatively good agreement with the medical record (52) . We have demonstrated previously that recall bias did not play a significant role in the characterization of childhood pneumonia in COPDGene, and that 96.1% of subjects reporting childhood pneumonia indicated that they had 
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pneumonia diagnosed by a medical provider (6) . The current study has limited power to detect significant variants at the strict genome-wide level. Although the GWAS meta-analysis includes 9,934 subjects, only 843 had childhood pneumonia and a significant proportion of these were in the NHW population. The childhood pneumonia meta-analysis was estimated to have 80% power to detect an SNP of MAF 0.2 with an odds ratio of 1.46 (53) . GWAS can require populations of 10-20 times this size to detect a significant variants (54) . Despite these limitations, there were a number of SNPs identified as approaching genome-wide significance and these may be involved in critical pathways related to lung growth and development, pulmonary function, and future respiratory disease susceptibility. To strengthen these findings, replication will be an important part of future investigations, followed by biologic validation of relevant genes.
Conclusions
Our childhood pneumonia GWAS in current and former adult smokers identified potential genes of interest related to lung growth and development, vascularization, lung function, and repair processes. Genes showing suggestive evidence of an association with childhood pneumonia have known relationships to acute lung injury, asthma, and COPD. Network analysis of childhood pneumonia genes implicated top networks related to development, particularly blood vessel morphogenesis, muscle contraction, and WNT signaling. These results could help explain a genetic predisposition for developing pneumonia during childhood and respiratory disease in adult smokers. Further exploration of the genetic susceptibility loci will be required to learn more about the pathways of disease association and to propose networks of disease susceptibility on the basis of these findings. n Author disclosures are available with the text of this article at www.atsjournals.org.
